Skip to main content

Find Clinical Trials

Home
Conditions
Esophageal Neoplasms

Clinical trial condition

Esophageal Neoplasms

Explore clinical trials studying Esophageal Neoplasms. Study availability and eligibility vary by location and protocol.

304 public trials 107 recruiting studies

Refine in advanced search Browse all conditions

Esophageal Neoplasms trial results

Not Yet Recruiting

Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC

NCT07618910

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: Tangdu Hospital Affiliated to the Fourth Military Medical University Xi'an, Shaanxi, China

View Trial Details

Not Yet Recruiting

Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

NCT07244978

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: The Second Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma

NCT07505186

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, China

View Trial Details

Not Yet Recruiting

Tumor Microenvironment Changes After Neoadjuvant Chemo-Immunotherapy in Esophageal Squamous Cell Carcinoma

NCT07482774

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Short-course Radiotherapy Combined With Serplulimab and Chemotherapy as Neoadjuvant Treatment for Resectable ESCC

NCT07403435

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma

NCT06952621

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Tangdu Hospitial, Xi'an, Shaanxi Rrovince Xi'an, Shaanxi, China

View Trial Details

Not Yet Recruiting

Standardized Management of Esophageal Fistula in Esophageal Squamous Cell Carcinoma

NCT07353541

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +18 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Multicenter Prospective Cohort on Esophageal Endoscopic Submucosal Dissection

NCT07343869

Conditions: Adenocarcinoma Of Esophagus, Barretts Esophagus With Dysplasia, Carcinoma, +17 more
Locations: Jules Verne Clinic Nantes, France

View Trial Details

Not Yet Recruiting

A Phase II Study of Toripalimab Plus Chemotherapy and Low-Dose Radiotherapy for Neoadjuvant Therapy-Refractory Esophageal Squamous Cell Carcinoma

NCT07272291

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.

NCT07251062

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: Not specified

View Trial Details